Herbal Medicine: Clinical Perspective and Regulatory Status

Author(s): Md. Abul Barkat*, Anjali Goyal, Harshita A. Barkat, Mohammad Salauddin, Faheem H. Pottoo, Esra T. Anwer

Journal Name: Combinatorial Chemistry & High Throughput Screening
Accelerated Technologies for Biotechnology, Bioassays, Medicinal Chemistry and Natural Products Research

Volume 24 , Issue 10 , 2021


Become EABM
Become Reviewer
Call for Editor

Abstract:

Herbal medicines play an important role in treating various ailments due to their potentially high therapeutic values and acceptability by patients with different health complications. The practice of herbal medicine involves the use of a part of a plant, the entire plant, or a selective isolated phytoconstituent. The search for new drugs during the scientific era revived the interest in the discovery of herbal drugs from different natural resources. The present modern healthcare system involves the utilization of drugs and 50% of them are of natural origin. In recent years, there had been an upsurge in the interest for search of novel herbal drugs by the pharmaceutical industry. However, the discovery of such new novel phytomedicines involves various challenges in the identification of active constituents; their characterization, pharmacological activity, toxicity/adverse effects, drug interactions, and, most importantly, their regulatory requirements. The present review is mainly focused on the history of herbal medicine, current clinical perspective, and pharmaceutical and regulatory challenges facing herbal drugs. Moreover, problems encountered in drug discovery from herbal resources and their possible solutions have been delineated.

Keywords: Phytomedicine, herbal medicine, phytotherapeutics, pharmaceutical industry, regulatory challenges, toxicity.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 24
ISSUE: 10
Year: 2021
Published on: 10 November, 2020
Page: [1573 - 1582]
Pages: 10
DOI: 10.2174/1386207323999201110192942
Price: $65

Article Metrics

PDF: 150